ClinicalTrials.Veeva

Menu

Intrawound Administration of Vancomycin in THA

Q

Qingdao University

Status

Completed

Conditions

Hip

Treatments

Procedure: Intrawound administration of vancomycin after closure of the arthrotomy

Study type

Interventional

Funder types

Other

Identifiers

NCT05338008
AHQingdao VancoTHA

Details and patient eligibility

About

The purpose of this study is to determine the intra-articular and serum levels of vancomycin over the first 24 hours postoperatively after intra-articular administration of a standard dose of vancomycin in primary total hip arthroplasty.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age over 18;
  2. Total hip arthroplasty for advanced hip diseases including femoral neck fracture, developmental dysplasia of hip, and osteonecrosis of the femoral head.

Exclusion criteria

  1. Diminished mental capacity
  2. Vancomycin allergy
  3. Chronic kidney disease stage III and stage IV

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 3 patient groups

Intrawound Administration of Vancomycin
Experimental group
Description:
After closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 20ml of normal saline was injected directly into the joint.
Treatment:
Procedure: Intrawound administration of vancomycin after closure of the arthrotomy
Intrawound Administration of Vancomycin combined with epsilon-aminocaproic acid (EACA)
Experimental group
Description:
After closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 4g (20ml) of epsilon-aminocaproic acid (EACA) was injected directly into the joint.
Treatment:
Procedure: Intrawound administration of vancomycin after closure of the arthrotomy
Intrawound Administration of epsilon-aminocaproic acid (EACA)
No Intervention group
Description:
After closure of the arthrotomy, 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 4g (20ml) of epsilon-aminocaproic acid (EACA) was injected directly into the joint.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems